Correlation Between BioNTech and Sellas Life

Can any of the company-specific risk be diversified away by investing in both BioNTech and Sellas Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Sellas Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioNTech SE and Sellas Life Sciences, you can compare the effects of market volatilities on BioNTech and Sellas Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Sellas Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Sellas Life.

Diversification Opportunities for BioNTech and Sellas Life

0.13

Correlation Coefficient

BioNTech  Sellas Life

Average diversification

The 3 months correlation between BioNTech and Sellas is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Sellas Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sellas Life Sciences and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Sellas Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sellas Life Sciences has no effect on the direction of BioNTech i.e., BioNTech and Sellas Life go up and down completely randomly.

Pair Corralation between BioNTech and Sellas Life

Given the investment horizon of 90 days BioNTech SE is expected to under-perform the Sellas Life. But the stock apears to be less risky and, when comparing its historical volatility, BioNTech SE is 2.33 times less risky than Sellas Life. The stock trades about -0.07 of its potential returns per unit of risk. The Sellas Life Sciences is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  99.00  in Sellas Life Sciences on December 28, 2024 and sell it today you would earn a total of  17.00  from holding Sellas Life Sciences or generate 17.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BioNTech SE  vs.  Sellas Life Sciences

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Sellas Life Sciences

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Sellas Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Sellas Life unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BioNTech and Sellas Life

The main advantage of trading using opposite BioNTech and Sellas Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Sellas Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sellas Life will offset losses from the drop in Sellas Life's long position.

The idea behind BioNTech SE and Sellas Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.